ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) - ANVISA Registration 80146502119

Access comprehensive regulatory information for ANTIGEN AND ANTIBODY TO HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, TYPE 2 AND TYPE 1 SUBGROUP O (HIV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80146502119 and manufactured by manufacturer not specified. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until May 21, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including QUIBASA QUÍMICA BÁSICA LTDA, SIEMENS HEALTHCARE DIAGNOSTICS INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80146502119
2 Related Devices
Registration Details
ANVISA Registration Number: 80146502119
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

80146502119

25351543448201711

56998701000116

Company Information

Dates and Status

May 21, 2018

21/05/2028

09/18/2025 19:00:01

Registration Details

80146502119

25351543448201711

56998701000116

Company Information

ABBOTT GMBH
Germany
PT: ALEMANHA

Dates and Status

May 21, 2018

21/05/2028

09/18/2025 19:00:01